These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
5. Synergistic effects of particulate matter and substrate stiffness on epithelial-to-mesenchymal transition. Barker TH, Dysart MM, Brown AC, Douglas AM, Fiore VF, Russell AG, HEI Health Review Committee. Res Rep Health Eff Inst; 2014 Nov; (182):3-41. PubMed ID: 25669020 [Abstract] [Full Text] [Related]
9. Epithin, a target of transforming growth factor-beta signaling, mediates epithelial-mesenchymal transition. Lee HS, Kim C, Kim SB, Kim MG, Park D. Biochem Biophys Res Commun; 2010 May 14; 395(4):553-9. PubMed ID: 20398629 [Abstract] [Full Text] [Related]
11. EGCG inhibits transforming growth factor-β-mediated epithelial-to-mesenchymal transition via the inhibition of Smad2 and Erk1/2 signaling pathways in nonsmall cell lung cancer cells. Liu LC, Tsao TC, Hsu SR, Wang HC, Tsai TC, Kao JY, Way TD. J Agric Food Chem; 2012 Oct 03; 60(39):9863-73. PubMed ID: 22957988 [Abstract] [Full Text] [Related]
12. NEDD9 crucially regulates TGF-β-triggered epithelial-mesenchymal transition and cell invasion in prostate cancer cells: involvement in cancer progressiveness. Morimoto K, Tanaka T, Nitta Y, Ohnishi K, Kawashima H, Nakatani T. Prostate; 2014 Jun 03; 74(8):901-10. PubMed ID: 24728978 [Abstract] [Full Text] [Related]
13. The dynamic roles of TGF-β in cancer. Meulmeester E, Ten Dijke P. J Pathol; 2011 Jan 03; 223(2):205-18. PubMed ID: 20957627 [Abstract] [Full Text] [Related]
20. SCUBE3 is an endogenous TGF-β receptor ligand and regulates the epithelial-mesenchymal transition in lung cancer. Wu YY, Peck K, Chang YL, Pan SH, Cheng YF, Lin JC, Yang RB, Hong TM, Yang PC. Oncogene; 2011 Aug 25; 30(34):3682-93. PubMed ID: 21441952 [Abstract] [Full Text] [Related] Page: [Next] [New Search]